aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
From
By
Invalid Date
Share:
Neurode wants to treat and track ADHD symptoms through a wearable headband
Attention deficit hyperactivity disorder (ADHD) affects more than 366 million adults globally, according to a 2020 study, but beyond medicating with stimulants like Adderall and Ritalin, there are few alternatives for people who suffer from the disorder. Therapy, education, and lifestyle changes are usually also advised, but those avenues can prove difficult as well. Sydney-based Neurode has come up with a novel way to offer some relief to people with ADHD: a wearable headband that can track an
Sep 10, 2024
French embedded insurance startup Neat secures $55 million
It’s not every day that you hear about a large funding round for a French startup in the current funding environment. But Neat, a Paris-based insurtech startup, has managed to raise €50 million (around $55 million at current exchange rates). There is some fine print however. In addition to the traditional equity-for-cash financial transaction, a portion of this funding round is a debt facility. It’s around 60% in equity and 40% in debt, according to the company. So it’s more like a €30 million
Sep 10, 2024
Mira is helping fill the hormone knowledge gap for women and the medical industry
Hormones play a massive role in when and how easily women can get pregnant, but research and resources in this area are lacking. Mira is looking to change that. Mira is an at-home, palm-sized hormone testing device women use to test their urine for their hormone levels. Mira’s corresponding app deciphers their results and spots patterns which help women better plan for the right time to try to get pregnant or know when it’s time to bring up potential issues with their doctor. Sylvia Kang, the c
Sep 10, 2024
Don't miss our latest news and updates. Subscribe to the newsletter